Meet the Editorial Board Member

Author:

Sapino Anna1

Affiliation:

1. Department of Medical Sciences University of Turin Turin Italy

Abstract

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology (medical),Cancer Research,Drug Discovery,Oncology,General Medicine

Reference5 articles.

1. Sebastian C.; Ferrer C.; Serra M.; Choi J-E.; Ducano N.; Mira A.; Shah M.S.; Stopka S.A.; Perciaccante A.J.; Isella C.; Moya-Rull D.; Vara-Messler M.; Giordano S.; Maldi E.; Desai N.; Capen D.E.; Medico E.; Cetinbas M.; Sadreyev R.I.; Brown D.; Rivera M.N.; Sapino A.; Breault D.T.; Agar N.Y.R.; Mostoslavsky R.; A Non-Dividing Cell Population with High Pyruvate Dehydrogenase Kinase Activity Regulates Metabolic Heterogeneity and Tumorigenesis in the Intestine. Nat Commun 2022,13(1),1503

2. Berrino E.; Filippi R.; Visintin C.; Peirone S.; Fenocchio E.; Farinea G.; Veglio F.; Aglietta M.; Sapino A.; Cereda M.; Visintin R.; Pasini B.; Marchiò C.; Collision of Germline POLE and PMS2 Variants in a Young Patient Treated with Immune Checkpoint Inhibitors. NPJ Precis Oncol 2022,6(1),15

3. Vavala T.; Malapelle U.; Veggiani C.; Ludovini V.; Papotti M.; Leone A.; Graziano P.; Minari R.; Bono F.; Sapino A.; Manotti L.; Troncone G.; Pisapia P.; Girlando S.; Buffoni L.; Righi L.; Colantonio I.; Bertetto O.; Novello S.; Molecular Profiling of Advanced Non-Small Cell Lung Cancer in the Era of Immunotherapy Approach: A Multicenter Italian Observational Prospective Study of Biomarker Screening in Daily Clinical Practice. J Clin Pathol 2022,75(4),234-240

4. Gunawardena S.A.; Cordeiro C.; Di Vella G.; Fernando D.; Rajapaksha S.; Samaranayake R.; Sapino A.; Tennakoon A.; Waduge S.; Woodford N.; Wijeratne S.; Zoja R.; Survey on Postmortem Screening and Management of COVID-19 Related Deaths. Pathologica 2021,113(6),413-420

5. Debernardi C.; Libera L.; Berrino E.; Sahnane N.; Chiaravalli A.M.; Laudi C.; Berselli M.; Sapino A.; Sessa F.; Venesio T.; Furlan D.; Evaluation of Global and Intragenic Hypomethylation in Colorectal Adenomas Improves Patient Stratification and Colorectal Cancer Risk Prediction. Clin Epigenetics 2021,13(1),154

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3